Elekta recently received FDA clearance for its Volumetric Modulated Arc Therapy (VMAT).
Reportedly empowering clinicians to treat more patients in significantly less time, Elekta VMAT offers the clinical efficacy of IMRT delivered in a fraction of the time, providing rapid treatment with daily 3D image guidance. Features of VMAT include faster treatment times, precise dose control, reduced radiation dose to healthy tissue and 3D Volumetric imaging.
March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...
March 28, 2024 
March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...
March 27, 2024 
In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...
March 19, 2024 
March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...
March 18, 2024 
Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...
March 06, 2024 
March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...
March 01, 2024 
February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...
February 22, 2024 
February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...
February 22, 2024 
February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...
February 14, 2024 
February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...
February 12, 2024